For many of China's biotech brains-in-exile, it's time to come home

SHANGHAI (Reuters) - In biotech parks across the Yangtze River Delta, dozens of start-ups are working to develop drugs to treat China's biggest emerging diseases - from diabetes and Hepatitis B to respiratory illnesses and cancer.